At a glance
- Originator Azwell
- Class Antihypertensives; Dihydropyridines
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Heart failure; Hypertension
Most Recent Events
- 20 Sep 1994 Discontinued-I for Angina pectoris in Japan (Unknown route)
- 20 Sep 1994 Discontinued-I for Congestive heart failure in Japan (Unknown route)